Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location

BACKGROUND: Postmenopausal hormone therapy (HT) is associated with a decreased colorectal cancer (CRC) risk. As CRC is a heterogeneous disease, we evaluated whether the association of HT and CRC differs across etiologically relevant, molecularly defined tumor subtypes and tumor location. METHODS: We...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:JNCI Cancer Spectr
المؤلفون الرئيسيون: Labadie, Julia D, Harrison, Tabitha A, Banbury, Barbara, Amtay, Efrat L, Bernd, Sonja, Brenner, Hermann, Buchanan, Daniel D, Campbell, Peter T, Cao, Yin, Chan, Andrew T, Chang-Claude, Jenny, English, Dallas, Figueiredo, Jane C, Gallinger, Steven J, Giles, Graham G, Gunter, Marc J, Hoffmeister, Michael, Hsu, Li, Jenkins, Mark A, Lin, Yi, Milne, Roger L, Moreno, Victor, Murphy, Neil, Ogino, Shuji, Phipps, Amanda I, Sakoda, Lori C, Slattery, Martha L, Southey, Melissa C, Sun, Wei, Thibodeau, Stephen N, Van Guelpen, Bethany, Zaidi, Syed H, Peters, Ulrike, Newcomb, Polly A
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2020
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477374/
https://ncbi.nlm.nih.gov/pubmed/32923935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa042
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة